The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia.
Saez Perdomo MN, Stuckey R, González-Pérez E, Sánchez-Sosa S, Estupiñan-Cabrera P, Lakhwani Lakhwani S, González San Miguel JD, Hernanz Soler N, Gordillo M, González Brito G, Tapia-Torres M, Ruano A, Segura-Díaz A, Luzardo H, Bilbao-Sieyro C, Gómez-Casares MT.
Saez Perdomo MN, et al. Among authors: ruano a.
Hematol Rep. 2024 Mar 12;16(1):140-150. doi: 10.3390/hematolrep16010015.
Hematol Rep. 2024.
PMID: 38534885
Free PMC article.